Aspen Aerogels Inc ASPN 深 沪
等待开盘 02-20 09:30:00 美东时间
3.62
+0.130
+3.72%
华盛通- 最 高3.66
- 今 开3.45
- 成交量 124.14万股
- 最 低 3.40
- 昨 收 3.49
- 总市值 2.99亿
- 52周最高 9.78
- 市盈率 静 21.73
- 换手率 1.50%
- 52周最低 2.795
- 委 比 99.57%
- 总股本 8264.71万
- 历史最高 65.986
- 量 比 1.05
- 振 幅 7.45%
- 历史最低 1.60
- 每 手 1
- 风险率 1.76%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多BRIEF-Aspen Aerogels on Dec 16 enters amendment No. 2 to credit agreement
Dec 18 (Reuters) - Aspen Aerogels Inc ASPN.N: ASPEN AEROGELS INC - ON DEC 16, ENTERS AMENDMENT NO. 2 TO CREDIT AGREEMENT - SEC FILING Further company coverage: ASPN.N ((Reuters.Briefs@thomsonreuters.c...
2025-12-18 19:11
Aspen Aerogels Announces Amendment to MidCap Credit Facility
Aspen Aerogels, Inc. has amended its existing credit agreement with MidCap Financial to enhance its financial position and provide additional flexibility. The amendment adjusts financial covenants and includes other technical updates. Aspen's CFO, Grant Thoele, highlighted improved liquidity due to operational efficiencies and expects to execute the company's strategy in 2026 with the new flexibility. The amendment will be filed with the SEC.
2025-12-17 23:30
美股大行评级 | 潜在涨幅1307.13%！HC Wainwright & Co.：Adicet Bio获机构升目标价至9美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从4美元升至9美元；Citizens: 维持Rapport Therapeutics"跑赢大市"评级，目标价从77美元升至80美元
2025-11-10 17:17
美股大行评级 | 潜在涨幅1307.13%！HC Wainwright & Co.：Adicet Bio获机构升目标价至9美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从4美元升至9美元；Citizens: 维持Rapport Therapeutics"跑赢大市"评级，目标价从77美元升至80美元
2025-11-10 10:22
U.S. RESEARCH ROUNDUP-Blackline, Carmax, Expedia
Nov 7 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies including Blackline, Carmax and Expedia on Friday. HIGHLIGHTS * Blackline Inc...
2025-11-07 14:57
BUZZ-U.S. STOCKS ON THE MOVE-AppLovin, Marvell Technology, Ralph Lauren
Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stock index futures were flat...
2025-11-06 22:23
Aspen Aerogels Q3 revenue drops 38%, adjusted EPS misses
Overview Aspen Aerogels Q3 2025 revenue fell to $73 mln from $117.3 mln in Q3 2024 Adjusted EPS for Q3 2025 missed analyst expectations Net loss for Q3 2025 improved to $6.3 mln from $13 mln in Q3 202...
2025-11-06 19:41
Aspen Aerogels shares are trading lower after the company lowered its full-year earnings and sales guidance.
Aspen Aerogels shares are trading lower after the company lowered its full-year...
2025-11-06 19:39
Aspen Aerogels Lowers FY2025 GAAP EPS Guidance from $(3.86)-$(3.73) to $(4.15)-$(4.05) vs $(3.82) Est; Lowers FY2025 Sales Guidance from $297.000M-$317.000M to $270.000M-$280.000M vs $303.592M Est
Aspen Aerogels (NYSE:ASPN) lowers FY2025 GAAP EPS guidance from $(3.86)-$(3.73) to $(4.15)-$(4.05) vs $(3.82) analyst estimate. Lowers FY2025 sales outlook from $297.000 million-$317.000 million to $270.000
2025-11-06 19:34
Aspen Aerogels Reports Q3 Revenue of $73 Million and Net Loss of $6.3 Million
Aspen Aerogels Inc. reported total revenue of $73.0 million for the third quarter of 2025, compared to $117.3 million in the same period of 2024. The company recorded a net loss of $6.3 million, which...
2025-11-06 19:30
